|Articles|October 14, 2019
Identification of Insulin Oligomeric States using SEC-MALS
Author(s)Wyatt
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
New $82 Million Biopharma Launch Targets Rare Disease Development With AI-Driven Strategy
2
Green Chemistry’s Role in Advancing US Chemical Innovation
3
Industry Outlook 2026: Biopharma Industry Confronts Skills Shortage with Strategic Automation (Part 2)
4
WHO Finalizes United States’ Withdrawal from Organization: Report
5